FindTrial
Sign In

Analysis of Gut Microbiota in patients with type 2 diabetes mellitus complicated with myocardial infarction

Gut Microbiota and Myocardial Infarction in Patients with Type 2 Diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063341
Enrollment
Unknown
Registered
2022-09-05
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes with myocardial infarction

Interventions

T2DM with myocardial infarction:None
T2DM:None

Sponsors

Affiliated Hospital of Jiaxing University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Fourth Universal Definition of Myocardial Infarction (2018) diagnostic criteria; 2. Standards of medical care in diabetes2014 diagnostic criteria

Exclusion criteria

Exclusion criteria: 1. Subjects suffering from diarrhea, inflammatory bowel disease or other infectious diseases; 2. The research subjects have autoimmune diseases or malignant tumors; 3. Received chemotherapy, radiotherapy or surgery recently; 4. The collected subjects have used antibiotics, steroid hormones, acid suppressants, Chinese herbal medicines, probiotics (such as yogurt), health products, etc. within 3 months or less; 5. Other organic diseases of the digestive system; 6. There is a history of digestive system surgery in the past; 7. Women in menstrual period.

Design outcomes

Primary

MeasureTime frame
16S rRNA Gene Sequencing;—

Countries

China

Contacts

Public ContactMengHui Mao

Affiliated Hospital of Jiaxing University

aimyon1314@gmail.com+86 15857206530

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026